DK0887418T3 - Use of ectoin and hydroxyectoin as a drug - Google Patents

Use of ectoin and hydroxyectoin as a drug

Info

Publication number
DK0887418T3
DK0887418T3 DK98113132T DK98113132T DK0887418T3 DK 0887418 T3 DK0887418 T3 DK 0887418T3 DK 98113132 T DK98113132 T DK 98113132T DK 98113132 T DK98113132 T DK 98113132T DK 0887418 T3 DK0887418 T3 DK 0887418T3
Authority
DK
Denmark
Prior art keywords
hydroxyectoin
state
cell contents
ectoin
drug
Prior art date
Application number
DK98113132T
Other languages
Danish (da)
Inventor
Erwin A Dr Galinski
Hans G Prof Dr Trueper
Thomas Sauer
Original Assignee
Bitop Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop Ag filed Critical Bitop Ag
Application granted granted Critical
Publication of DK0887418T3 publication Critical patent/DK0887418T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Cell contents are obtained from cells in vivo by transforming cells from a first state into a second state by subjecting them to stress conditions such that they are forced either to release cell contents into their environment or to synthesize cell contents in order to adapt themselves to the conditions of the second state; the procedure being repeated at least twice reverse stress. S,S-Alpha-amino-beta-hydroxyectoin of formula (I) is also claimed.
DK98113132T 1992-12-31 1993-12-24 Use of ectoin and hydroxyectoin as a drug DK0887418T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4244580A DE4244580A1 (en) 1992-12-31 1992-12-31 Process for the in vivo extraction of ingredients from cells

Publications (1)

Publication Number Publication Date
DK0887418T3 true DK0887418T3 (en) 2003-02-24

Family

ID=6476850

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98113132T DK0887418T3 (en) 1992-12-31 1993-12-24 Use of ectoin and hydroxyectoin as a drug
DK94903874T DK0677044T3 (en) 1992-12-31 1993-12-24 Method for extracting cellular components in vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK94903874T DK0677044T3 (en) 1992-12-31 1993-12-24 Method for extracting cellular components in vivo

Country Status (7)

Country Link
EP (4) EP1493432A1 (en)
AT (3) ATE284448T1 (en)
DE (4) DE4244580A1 (en)
DK (2) DK0887418T3 (en)
ES (2) ES2234065T3 (en)
PT (1) PT887418E (en)
WO (1) WO1994015923A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342560A1 (en) * 1993-12-14 1995-06-22 Marbert Gmbh Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics
DE4427617B4 (en) * 1994-08-04 2005-09-01 bitop Aktiengesellschaft für biotechnische Optimierung Process for obtaining cell components from halophilic and osmophilic as well as halo and osmotolerant microorganisms
DE19711082A1 (en) * 1997-03-18 1998-09-24 Degussa Process for the separation of tetrahydropyrimidines from aqueous solutions
WO2000076528A2 (en) * 1999-06-12 2000-12-21 Bitop Gmbh Pharmaceutical preparation containing proteins
EP1125583A1 (en) * 2000-02-14 2001-08-22 Bitop Gesellschaft für biotechnische Optimierung MbH Use of compatible solutes as inhibitors of the enzymatic degradation of macromolecular biopolymers
DE10014632A1 (en) * 2000-03-24 2001-09-27 Merck Patent Gmbh Protection of stress proteins in the skin using ectoine or its derivatives, is useful in topical skin care or make-up cosmetic compositions for maintaining the defense mechanism of the skin
US7048910B2 (en) 2000-09-07 2006-05-23 Merck Patent Gmbh Use of ectoine or ectoine derivatives for oral care
DE10214257A1 (en) 2002-03-28 2003-10-16 Merck Patent Gmbh Use of compatible solutes to inhibit the release of ceramides
DE10330768A1 (en) 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Use of osmolytes obtained from extremophilic bacteria for the preparation of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases, and an inhalation device containing osmolyte as an active ingredient
SG151298A1 (en) 2004-04-08 2009-04-30 Biomatrica Inc Integration of sample storage and sample management for life science
DE102006060953A1 (en) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Synergistic preparation for treating urinary tract inflammation, e.g. cystitis, contains low molecular hyaluronic acid and another glycosaminoglycan, preferably chondroitin sulfate
DE102007003765A1 (en) 2007-01-19 2008-07-24 Farco-Pharma Gmbh Pharmaceutical composition for the treatment of incontinence
DE102007013857A1 (en) 2007-03-20 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh New compositions, especially for the topical treatment of skin diseases
DE102007052380A1 (en) 2007-10-31 2009-05-07 Bitop Ag Osmolyte-containing preparations for use in dry mucous membranes
DE102008006780A1 (en) * 2008-01-30 2009-08-06 Bitop Ag Use of tetrahydropyrimidines
DE102008036725B4 (en) 2008-08-07 2021-01-28 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmaceutical composition for nasal application
DE102008045237B4 (en) 2008-08-28 2010-07-29 Helmholtz-Zentrum Für Umweltforschung Gmbh - Ufz Method for the simultaneous production of PHA and compatible solutes in halophilic bacteria
US10463891B2 (en) 2008-09-30 2019-11-05 Symrise Ag Extracts of Isochrysis sp.
EP2193785B1 (en) 2008-12-05 2018-07-18 Symrise AG Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes
DE102010010277A1 (en) * 2009-03-07 2011-07-14 Hertel, Marcus, Dr.-Ing. Method and device for yeast vitalization in the course of a brewing process
US8519125B2 (en) 2009-05-11 2013-08-27 Biomatrica, Inc. Compositions and methods for biological sample storage
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
JP5933544B2 (en) 2010-07-26 2016-06-08 バイオマトリカ， インコーポレーテッド Compositions for stabilizing blood DNA, RNA and proteins and other biological samples shipped and stored at ambient temperature
DE102011113059A1 (en) 2011-09-09 2013-03-14 Bitop Ag Therapeutic Applications of Ectoin
DE102012000416A1 (en) 2011-11-24 2013-05-29 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Topical composition, useful for treating wounds, preferably open wounds and ulcers, comprises fusafungine and/or one of its derivative and onion extract
DE202012000250U1 (en) 2011-11-24 2012-12-05 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Composition for topical application I
DE202011109558U1 (en) 2011-12-09 2012-12-12 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Composition for topical use in inflammatory diseases of the skin and / or mucosa
EP2636750A1 (en) 2012-03-06 2013-09-11 Roche Diagniostics GmbH Compatible solute ectoine as well as derivatives thereof for enzyme stabilization
DE102012005177A1 (en) * 2012-03-16 2013-09-19 Bitop Ag Organ storage solution
EP2934572A4 (en) 2012-12-20 2016-11-23 Biomatrica Inc Formulations and methods for stabilizing pcr reagents
ES2701758T3 (en) 2013-02-27 2019-02-25 Symrise Ag Ginger extract for the protection of stem cells
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
EP2921157B1 (en) 2014-03-18 2017-08-16 Symrise AG Coated titanium dioxide to reduce whitening effect on skin
ES2819207T3 (en) 2014-04-29 2021-04-15 Symrise Ag Active mixes
EP3656215B1 (en) 2014-06-10 2021-08-04 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
EP3045161A1 (en) 2015-01-18 2016-07-20 Symrise AG Active compositions comprising 1,2-hexanediol and 1,2-octanediol
AU2016368265B2 (en) 2015-12-08 2021-10-28 Biomatrica, Inc. Reduction of erythrocyte sedimentation rate
DE102017105010A1 (en) 2017-02-24 2018-08-30 Farco-Pharma Gmbh Composition, in particular gel, for use in the genitourinary tract
EP3592329A1 (en) 2017-03-06 2020-01-15 Merck Patent GmbH Use of compatible solutes
CN107333750A (en) * 2017-06-11 2017-11-10 成都吱吖科技有限公司 Blood cell stabilizer when a kind of long
JP2022543068A (en) 2019-08-01 2022-10-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Prevention and reduction of keratinization disorders and related cosmetic agents
EP4424809A1 (en) 2023-03-03 2024-09-04 FCC Aqualia, S.A. Method for converting methane-containing gas streams into osmolytes using a bacteria culture in a taylor-flow bioreactor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286660A (en) * 1979-03-23 1981-09-01 Gesellschaft Fur Biotechnologische Forschung Gmbh Process and installation for the flooding of petroleum deposits and oil shale
US4720458A (en) * 1983-10-19 1988-01-19 Sullivan Cornelius W Heat sensitive bacterial alkaline phosphatase
DE3515650A1 (en) * 1985-05-02 1986-11-06 Biochemie GmbH, Kundl, Tirol METHOD FOR SEPARATING BIOTECHNOLOGICALLY PRODUCED VALUABLES BY CROSS-CURRENT MICROFILTRATION
JPH0759545B2 (en) * 1987-06-17 1995-06-28 富士写真フイルム株式会社 Base precursor
FR2635113B1 (en) * 1988-08-05 1992-07-24 Sanofi Sa PROCESS FOR OBTAINING MATURE INTERLEUKIN-1 (BETA) FROM E CELLS. COLI TRANSFORMED
JPH0331265A (en) * 1989-06-26 1991-02-12 Takeda Chem Ind Ltd Production of tetrahydropyrimidine derivatives
WO1992004054A1 (en) * 1990-08-30 1992-03-19 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon Substituted amidines having high binding to the sigma receptor and the use thereof
IL100810A (en) * 1992-01-30 1996-12-05 Yeda Res & Dev Pharmaceutical compositions comprising 2-methyl-4-carboxy-5-hydroxy-tetrahydropyrimidine and/or 2-methyl-4-carboxy-tetrahydropyrimidine methods for the isolation and purification of said compounds and substantially pure 2-methyl-4-carboxy-5-hydroxy-3, 4, 5, 6-tetrahydropyrimidine salts 5-ethers and 5-esters thereof

Also Published As

Publication number Publication date
EP0887418A3 (en) 1999-01-13
EP0887418B1 (en) 2002-10-30
DE59310369D1 (en) 2005-01-13
DE59310311D1 (en) 2002-12-05
ATE284448T1 (en) 2004-12-15
EP0677044B1 (en) 1998-10-28
EP0677044A1 (en) 1995-10-18
WO1994015923A3 (en) 1994-09-29
EP1493432A1 (en) 2005-01-05
ES2186059T3 (en) 2003-05-01
DE4244580A1 (en) 1994-07-07
EP0915167B1 (en) 2004-12-08
ATE172750T1 (en) 1998-11-15
DE59309101D1 (en) 1998-12-03
WO1994015923A2 (en) 1994-07-21
ES2234065T3 (en) 2005-06-16
EP0887418A2 (en) 1998-12-30
EP0915167A1 (en) 1999-05-12
ATE226943T1 (en) 2002-11-15
PT887418E (en) 2003-03-31
DK0677044T3 (en) 1999-07-12

Similar Documents

Publication Publication Date Title
DK0887418T3 (en) Use of ectoin and hydroxyectoin as a drug
ATE360622T1 (en) SUBSTITUTED 2-ARYL-4-AMINO-QUINAZOLINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
NO943347L (en) Halichondrins and related compounds
DK0646595T3 (en) Nucleic acid-binding oligomers with N-branching for therapy and diagnostics
ATE252825T1 (en) EXTENDED STORAGE OF RED BLOOD CELLS
DE3775872D1 (en) SALICYL ACID AMIDES, METHOD FOR THEIR PRODUCTION AND THEIR USE.
ATE177424T1 (en) N-SUBSTITUTED NAPHTHALIMIDES, THEIR PRODUCTION AND USE
DK90088D0 (en) CARBOMYCIN BIOSYNTH SYNTHESIS, USED CARG, FOR USE IN STREPTOMYCES AND OTHER MICROORGANISMS
ATE61589T1 (en) ISOHEXIDE NUCLEOSIDES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
CA2326056A1 (en) Direct synthesis process of indium phosphide
WO1988003922A3 (en) Thiophenesulfonamide herbicides
ATE9337T1 (en) N-SUBSTITUTED 2-METHYLNAPHTHYLAMIDES, PROCESS FOR THEIR PRODUCTION AND USE TO COMBAT FUNGI.
IT8920903A0 (en) PROCEDURE FOR THE PRODUCTION OF COKE.
RU1816761C (en) Method of synthesis of substituted 1-alkoxycarbonylmethyl-1,2-dihydro-3h-1,4- benzdiazepine-2-ones
DE59005353D1 (en) 1-bromo-3-chloro-1,2-diaryl-2-propanols, process for the stereoselective preparation of the erythro-1-bromo-3-chloro-1,2-diaryl-2-propanols and their conversion to azolylmethyloxiranes.
FI960588A (en) Thiocarbamoyl compounds useful as microbicides
ATE125816T1 (en) OASOMYCINS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE.
ATE111903T1 (en) SUBSTITUTED 1.2.3.4-OXATRIAZOLIUM-5-OLATES, PROCESS FOR THEIR PRODUCTION AND USE.
NO159184C (en) PROCEDURE FOR BUILDING LARGE MODULES AND THE MODULE MANUFACTURED BY THE PROCEDURE.
ATE128970T1 (en) TRIFLUOR OR CHLORDIFLUOROMETHOXY-1,3,5,- TRIAZINES AND METHOD FOR THE PRODUCTION THEREOF.
SE8602148D0 (en) RAM OR BEAUTIFUL
TH24381B (en) Substituted benzoyl guanidine, preparation method The use of these substances as drugs or diagnostic substances. And drugs containing these substances
JPS52110889A (en) Immobilization of yeast or microbial cells
DK163886D0 (en) PROCEDURE AND TRANSPORTATION FOR THE CREATION OF A SUBJECT LINE ARE EASY TO SEPARATE SEPARATE SUBJECTS FROM AN INCLUDED IRREGULAR SERIES OF SUBJECTS, EX. SPISEISKARTONER
IT8621870A0 (en) ADHESIVE MASSES, FOR THE PRODUCTION OF SELF-ADHESIVE TAPES, OBTAINED BY GRADING POLYMERIZATION, AND RELATED PREPARATION PROCEDURE.